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 Latin America: Should We Be Worried 
about Zika Virus?
To the Editor,
The Zika virus (ZIKV) was identified for the first time in 1947, 
almost 70 years ago. Despite being known during all these de-
cades, it has been neglected until the current outbreak in Bra-
zil. This an emergent disease that has been developing slowly 
throughout these years; we still have limited information and 
scientific knowledge about this illness and its potential out-
comes.1
This infection causes fairly mild effects, as 80% of the patients 
go unnoticed.2 The most common symptoms are fever, rash, 
joint pain, and conjunctivitis, which last for several days to a 
week after the infection.3 The primary mode of transmission is 
through the bite of an infected mosquito of the Aedes species. 
Apart from mosquitoes, other non-vector means of transmis-
sion are sexual intercourse and during pregnancy. Furthermore, 
there is a strong possibility that ZIKV can be spread through 
blood transfusions. It is suggested that breastfeeding could be 
another way of transmission, due to the fact that it has been 
found in breast milk. However, there are no reports up to date 
about other means of transmission. Because of the benefits of 
breastfeeding, mothers are encouraged to breastfeed even in 
areas where ZIKV is found (Available from: http://www.cdc.gov/
zika/about/overview.html; cited 2016 Jul 28).
Since ZIKV can cross the blood brain barrier,4 a relationship 
with some severe congenital neurologic defects, such as mi-
crocephaly and Guillian-Barré syndrome, has been established. 
Mlakar et al described that the cases of microcephaly increased 
by a factor of 20 among newborns in the northeast of Brazil.4,5 
Many other authors also describe severe brain injuries, inflam-
matory signs and calcifications, leading them to think that it is 
likely that an intrauterine infection brings about the abnormal 
brain development, and can lead to cerebral palsy after birth.1-3 
It is also suggested that the low maternal supplementation of 
nutrients may affect other organs as well,6 although this is yet 
to be determined.
The World Health Organization declared ZIKV a ‘Public Health 
Emergency of International Concern”;7 as it threatens to beco-
me a global pandemic. Up to date, there is no cure or vaccine 
available (Available from: http://www.cdc.gov/zika/about/over-
view.html; cited 2016 Jul 28). There are different methods for 
diagnosing ZIKV. One of them is the real-time reverse transcrip-
tion-polymerase chain reaction (rRT-PCR), which must only be 
conducted on urine or serum samples collected during the first 
14 days after symptoms onset. This test has a high sensitivity 
and a poor specificity. If the rRT-PCR is negative in a high risk 
patient, the ELISA for qualitative detection of IgM (Zika MAC-ELI-
SA) is used.8 However, a cross-reaction with other flaviviruses 
is present, as such the test has poor specificity in people living 
in endemic areas that have been previously exposed to the 
dengue and yellow fever viruses.6-9 Therefore, results may be 
difficult to interpret in Latin America. 
System-wide barriers impede health care delivery in our region. 
Latin American health providers have the obligation to gene-
rate awareness amongst our people about ZIKV. The need for 
a stronger surveillance system, suitable diagnostics methods, 
communication about ZIKV outbreak risks, vector control and 
adequate guidance to pregnant women is necessary.3
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 Methylprednisolone-Responsive Lep-
tospiral Acute Pulmonary Syndrome
To the Editor,
The article by Johan-Arief et al highlights the role of early me-
thylprednisolone therapy to reduce morbidity and mortality of 
the acute pulmonary syndrome in leptospirosis,1 and the au-
thors emphasize the ideal administration of this drug within 
12 hours after diagnosis. They reported a 26-year-old man with 
fever of one-week duration, who on the third day had presen-
ted with cough and breathlessness, and episodes of hemop-
tysis occurred two days later.1 His professional work involved 
frequent close contact with soil, and he was swimming in a 
waterfall a week before the onset of the high-grade fever asso-
ciated with chills, rigors and body aches.1 Physical signs were 
jaundice, subconjunctival suffusion, and bilateral pulmonary 
crepitations. Blood tests showed neutrophilic leucocytosis, low 
platelets, disordered coagulation, liver and renal functions; and 
the chest x-ray revealed scattered alveolar infiltrates. The Weil’s 
disease was diagnosed by positive IgM ELISA, and the specific 
microscopic agglutination test (1:400).1 Intravenously, he un-
derwent transexamic acid (500 mg 3 times daily), plus benzyl 
penicillin (1200 mg every 6 hours) during a week, and methyl-
prednisolone (15 mg/kg daily) for 3 days.1 His clinical respon-
se to treatment was good and he was soon discharged home 
asymptomatic. Environmental factors and typical features of 
severe leptospirosis raised the diagnostic suspicion; as the ear-
ly diagnosis is the cornerstone of prompt adequate treatment 
of severe leptospirosis, one must consider some main concerns 
that constitute frequent challenges in clinical practice.2,3 During 
the first week of acute leptospirosis, the blood borne bacteria 
almost invariably do not evoke an immune response enough 
to yield antibody levels and false negative tests can occur;1-3 
so, the goal of starting adequate therapy within the first se-
ven days of disease may be hindered.3 Pulmonary involvement 
with hemoptysis has been more often reported in severe Weil’s 
disease, and the coexistence of accentuated thrombocytopenia 
may play a role on the poorest prognoses. Significant pulmo-
nary changes as well as low platelet counts can pose other 
concerns about diagnostic pitfalls with Hantavirus and dengue 
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infections, especially in developing countries.2-5 Since the first 
reports in North American Indians, the possibility of mistakes 
involving the acute pulmonary syndrome caused by leptospi-
rosis and HPS was commented in Brazilian Journals.4 Brazilian 
authors described a 19-year-old man with the diagnosis of 
anicteric leptospirosis, who had a productive cough without 
hemoptysis, reduced lung sounds on the right lower third of 
the thorax, and normal kidney function. Images of computed 
tomography confirmed the acute inflammatory process in the 
right lung, and he underwent a successful course of intrave-
nous ceftriaxone.3 Worthy of note, the patient had clinical and 
electrocardiographic findings of pericarditis; moreover, the 
count of bands was high (up to 1020) and the platelet count 
was low (82 × 109/L). Although not confirmed, these clinical 
and complementary findings were suggestive of HPS; a condi-
tion that has been described in the Brazilian Central Plateau 
either isolated or as a coinfection.3-5 On a practical standpoint, 
corticosteroids have been useful to control both the syndro-
mes.1,5
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